Warning! GuruFocus detected
1 Severe warning sign
with GABA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Gabather AB
ISIN : SE0010869552
Compare
Compare
Traded in other countries / regions
GABA.Sweden5J2.Germany IPO Date
2014-11-03Description
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -2.28 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 32.5 | |||||
| 3-Year EPS without NRI Growth Rate | 32.8 | |||||
| 3-Year FCF Growth Rate | 48.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.37 | |||||
| 9-Day RSI | 38.87 | |||||
| 14-Day RSI | 40.56 | |||||
| 3-1 Month Momentum % | -51.33 | |||||
| 6-1 Month Momentum % | -58.68 | |||||
| 12-1 Month Momentum % | -84.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | |||||
| Quick Ratio | 0.3 | |||||
| Cash Ratio | 0.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.4 | |||||
| Shareholder Yield % | -53.03 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -198.67 | |||||
| ROIC % | -114.04 | |||||
| 3-Year ROIIC % | 684.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.01 | |||||
| EV-to-EBITDA | -1.01 | |||||
| EV-to-FCF | -2.2 | |||||
| Earnings Yield (Greenblatt) % | -98.7 | |||||
| FCF Yield % | -39.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gabather AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.101 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.13 | ||
| 3-Year Sortino Ratio | -0.27 | ||
| Volatility % | 199.98 | ||
| 14-Day RSI | 40.56 | ||
| 14-Day ATR (kr) | 0.008168 | ||
| 20-Day SMA (kr) | 0.04568 | ||
| 12-1 Month Momentum % | -84.82 | ||
| 52-Week Range (kr) | 0.026638 - 0.641307 | ||
| Shares Outstanding (Mil) | 236.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gabather AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gabather AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gabather AB Frequently Asked Questions
What is Gabather AB(OSTO:GABA)'s stock price today?
The current price of OSTO:GABA is kr0.04. The 52 week high of OSTO:GABA is kr0.64 and 52 week low is kr0.03.
When is next earnings date of Gabather AB(OSTO:GABA)?
The next earnings date of Gabather AB(OSTO:GABA) is 2025-05-30 Est..
Does Gabather AB(OSTO:GABA) pay dividends? If so, how much?
Gabather AB(OSTO:GABA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers